Top Markets
Coin of the day
Phoenix Biotech Acquisition Corp. Phoenix Biotech Acquisition Corp.

Phoenix Biotech Acquisition Corp.

PBAX
Rank in Stocks #15372
Phoenix Biotech Acquisition Corp. currently lacks substantial business... Phoenix Biotech Acquisition Corp. currently lacks substantial business operations. The company's primary objective is to complete a strategic business combination, such as a merger, asset acquisition, share exchange, or other form of reorganization, with one or more suitable enterprises. Its focus is on identifying and integrating with a firm engaged in the healthcare or healthcare-related industries within the United States or Europe. This entity was established in 2021 and maintains its headquarters in Oakland, California.
Share Price
$5.85
Last synced: 2024-02-14
Market Cap
$356.42M
Change (1 day)
4.65%
Change (1 year)
0.00%
Country
US
Trade Phoenix Biotech Acquisition Corp. (PBAX)
Operating Margin for Phoenix Biotech Acquisition Corp. (PBAX)
Operating Margin as of 2026 TTM: 0.00%
According to Phoenix Biotech Acquisition Corp. latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Phoenix Biotech Acquisition Corp. from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
US
0.00% -
US
0.00% -
CN
0.00% -
US
0.00% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.